All articles tagged with #vinay prasad
An opinion piece argues that FDA leaders Peter Marks and Vinay Prasad have pursued a rigorous, aggressive regulatory approach that comes with costs for biotech firms and patients, fueling debate over approving drugs with uncertain benefits.
AP reports that FDA Commissioner Marty Makary’s voucher-based effort to accelerate drug approvals into a one-month window has stirred alarm inside the agency. Questions swirl over who has legal authority to sign off on these expedited approvals, with senior officials and political appointees increasingly involved in the process, diverging from the traditional scientist-led review. The program, not codified in federal rules and now expanded to 18 vouchers, has coincided with staff layoffs and leadership turnover, fueling concerns about politicization, safety standards, and potential legal risk for the agency as critics warn that such rapid reviews lack scientific precedent.
Biotech shares experienced volatility following the surprise reinstatement of FDA official Vinay Prasad, whose return raises concerns about political influence affecting drug approval processes amid leadership turmoil within the FDA, impacting companies like Sarepta and Replimune.
The FDA has rehired Dr. Vinay Prasad as the head of its vaccines and gene therapy division after he resigned due to pressure from Laura Loomer, a far-right activist, despite opposition from key officials. Prasad, known for his vaccine skepticism, was previously appointed by Health Secretary RFK Jr. and had limited COVID-19 vaccine use. His reappointment has sparked controversy, especially among Trump supporters.
Vinay Prasad, who briefly left the FDA amid controversy, has returned to oversee vaccine, gene therapy, and blood products, following pressure and criticism related to his handling of gene therapy safety issues and political attacks from Laura Loomer.
Vinay Prasad, a top FDA official overseeing vaccines and treatments, has been reinstated less than two weeks after being ousted at the White House's direction, following a right-wing pressure campaign.
Dr. Vinay Prasad, who was ousted from the FDA after criticism and controversy, has been rehired to lead the agency's biologics division, highlighting political influence and ongoing debates over drug and vaccine approval processes.
Dr. Vinay Prasad, who resigned from the FDA amid political pressure and criticism from right-wing activist Laura Loomer, has returned to his role at the agency, specifically leading the Center for Biologics Evaluation and Research, after a brief departure caused by internal and external political conflicts.
Vinay Prasad is returning to the FDA to resume his role overseeing biologics, including vaccines and gene therapy, after a brief departure amid tensions related to a Duchenne muscular dystrophy gene therapy and political criticisms.
Vinay Prasad, a UCSF professor and former FDA official, resigned after being labeled a 'leftist saboteur' by a right-wing conspiracy theorist, amid political tensions surrounding health policy.
Vinay Prasad, a prominent FDA regulator known for his rigorous approach to drug approval and skepticism of experimental therapies, was ousted amid political pressure and internal conflicts within the Trump administration, highlighting the influence of diverse political and advocacy groups on the agency's decision-making process.
Vinay Prasad, a dedicated and intelligent physician, recently left his role at the FDA amid controversy over drug safety and political pressures, highlighting the challenges of maintaining scientific integrity in regulatory decisions.
The article discusses the controversial ousting of Dr. Vinay Prasad from the FDA amid political and media attacks, critiques President Trump's EU trade deal as ineffective, covers cultural debates sparked by Sydney Sweeney's ad, and reports on various global political and economic issues including tariffs, legal cases, foreign investments, and military enlistment policies.
Dr. Vinay Prasad, a prominent FDA official known for advocating rigorous drug approval and criticizing industry overreach, resigned amid a smear campaign by political and industry allies, highlighting ongoing conflicts between public health interests and industry influence.
Dr. Vinay Prasad, a controversial FDA official known for his criticism of COVID-19 booster approvals, has left the agency citing a desire to avoid distraction and spend more time with family. His tenure included efforts to limit vaccine recommendations and override agency staff, and he was publicly supported by FDA leadership despite political attacks.